Catalyst

Slingshot members are tracking this event:

Aerie Pharmaceuticals (AERI) Releases Positive Phase 3 Data on Roclatan for Lowering Intraocular Pressure (IOP) in Patients with Glaucoma or Ocular Hypertension

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PFE

100%
AERI

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 14, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Roclatan, Phase 3 Data, Top Line Results, Intraocular Pressure, Glaucoma, Ocular Hypertension, Xalatan